Arch Biopartners Inc (ACHFF)
1.22
-0.02
(-1.61%)
USD |
OTCM |
May 23, 11:38
Arch Biopartners Total Liabilities (Quarterly): 4.786M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.786M |
September 30, 2023 | 4.915M |
June 30, 2023 | 5.411M |
March 31, 2023 | 6.746M |
December 31, 2022 | 3.822M |
September 30, 2022 | 3.724M |
June 30, 2022 | 4.517M |
March 31, 2022 | 4.736M |
December 31, 2021 | 4.360M |
September 30, 2021 | 5.136M |
March 31, 2021 | 4.815M |
December 31, 2020 | 4.339M |
September 30, 2020 | 3.444M |
June 30, 2020 | 3.233M |
March 31, 2020 | 2.852M |
December 31, 2019 | 2.761M |
September 30, 2019 | 2.621M |
June 30, 2019 | 2.464M |
March 31, 2019 | 1.818M |
December 31, 2018 | 1.617M |
September 30, 2018 | 1.330M |
June 30, 2018 | 1.253M |
March 31, 2018 | 1.268M |
December 31, 2017 | 0.8951M |
September 30, 2017 | 0.5076M |
Date | Value |
---|---|
June 30, 2017 | 0.4321M |
March 31, 2017 | 0.4101M |
December 31, 2016 | 0.4284M |
September 30, 2016 | 0.3854M |
June 30, 2016 | 0.382M |
March 31, 2016 | 0.3783M |
December 31, 2015 | 0.3385M |
September 30, 2015 | 0.3784M |
June 30, 2015 | 0.3316M |
March 31, 2015 | 0.3281M |
December 31, 2014 | 0.3951M |
September 30, 2014 | 0.3695M |
June 30, 2014 | 0.4538M |
March 31, 2014 | 0.4041M |
December 31, 2013 | 0.4856M |
September 30, 2013 | 0.448M |
June 30, 2013 | 0.4563M |
March 31, 2013 | 0.4567M |
December 31, 2012 | 0.427M |
September 30, 2012 | 0.4579M |
June 30, 2012 | 0.404M |
March 31, 2012 | 0.4276M |
December 31, 2011 | 0.403M |
September 30, 2011 | 0.3826M |
June 30, 2011 | 0.4094M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.464M
Minimum
Jun 2019
6.746M
Maximum
Mar 2023
4.149M
Average
4.350M
Median
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.4798M |
Shareholders Equity (Quarterly) | -4.307M |